The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten-Reference-Cited by-同舟云学术

The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten

Published:2018-08-24 Issue:8 Volume:14 Page:e1007630
ISSN:1553-7404
Container-title:PLOS Genetics
language:en
Short-container-title:PLoS Genet

Author:

Liang Xiaohuan,Daikoku Takiko,Terakawa Jumpei,Ogawa Yuya^ORCID,Joshi Ayesha R.,Ellenson Lora H.,Sun Xiaofei^ORCID,Dey Sudhansu K.

Funder

National Cancer Institute

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Public Library of Science (PLoS)

Subject

Cancer Research,Genetics(clinical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics

Reference55 articles.

1. Cancer Facts & Figures 2017: American Cancer Society, Atlanta; 2017. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf.

2. Endometrial Cancer: American Cancer Society; 2016. Available from: https://www.cancer.org/content/dam/cancer-org/cancer-control/en/cancer-types/endometrial-cancer-complete.pdf.

3. Update on prognostic markers for endometrial cancer;PS Binder;Womens Health (Lond),2014

4. PTEN1 is frequently mutated in primary endometrial carcinomas;D Kong;Nat Genet,1997

5. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma;RL Levine;Cancer Res,1998

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen-responsive FOXP4 is a target for endometrial carcinoma;Communications Biology;2024-06-18

2. Cancer risk and male Infertility: Unravelling predictive biomarkers and prognostic indicators;Clinica Chimica Acta;2024-05

3. In Vivo Intra‐Uterine Delivery of TAT‐Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53‐Deficient Endometrial Cancers;Advanced Science;2023-09-25

4. In vivointra-uterine delivery of TAT-fused Cre recombinase and CRISPR/Cas9 editing unveil histopathology of Pten/p53-deficient endometrial cancers;2023-06-08

5. Transient and DNA‐free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis;Cancer Communications;2023-02-10